Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Jun 2026 for Spero Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Scott Thomas Jackson: trading record in brief
This profile gathers the share dealings of Scott Thomas Jackson across 3 companies, led by Spero Therapeutics, Inc., Macrogenics Inc and Crescent Biopharma, Inc. Between 18 May 2021 and 23 June 2026, the trades on record add up to 8 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 25 June 2026: a share grant, in Spero Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Scott Thomas Jackson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
10,000 sharesCommon StockSEC:0001193125-26-283202:0
20,000 shares0Common StockSEC:0000950170-25-087017:0
6,500 sharesCommon StockSEC:0001125345-25-000083:0
20,000 shares0Common StockSEC:0000950170-24-066652:0
4,500 shares0Common StockSEC:0001125345-24-000107:0
20,000 shares0Common StockSEC:0000950170-23-052693:0
15,000 shares0Common StockSEC:0000899243-22-031505:0
5,250 shares0Common StockSEC:0001209191-21-036382:0
8 of 8 declarations
